IMMUNOGENICITY OF VIBRIO-CHOLERAE GHOSTS FOLLOWING INTRAPERITONEAL IMMUNIZATION OF MICE

被引:26
作者
EKO, FO [1 ]
HENSEL, A [1 ]
BUNKA, S [1 ]
LUBITZ, W [1 ]
机构
[1] UNIV VET MED,INST BACTERIOL & ANIM HYG,A-1030 VIENNA,AUSTRIA
基金
奥地利科学基金会;
关键词
VIBRIO CHOLERAE; GHOSTS; VIBRIOCIDAL TITER; SERUM IGG ANTIBODY; SEROCONVERSION;
D O I
10.1016/S0264-410X(94)80061-4
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The immunogenic potential of Vibrio cholerae ghosts (VCG) in comparison with heat-killed whole-cell vibrios (WCV) was evaluated after intraperitoneal immunization of adult mice. Swiss white mice received four doses of VCG or WCV intraperitoneally, consisting of 500 mu g of lyophilized material in 200 mu l of PBS. Serum samples were collected from all mice on the day of immunization and on days 14, 24, 35 and 62 postimmunization. Sera were examined for vibriocidal antibodies by the microtitre and tube-dilution methods and Vibrio-specific serum IgG antibodies were assessed by ELISA. IgG antibodies to intact WCV were detected in sera from all animals immunized with VCG or WCV. The response was specific and of high magnitude. Significantly higher antibody responses were obtained when sera from both VCG- and WCV-immunized mice were titrated against VCG. The immunogenicity of VCG in evoking serum IgG responses was higher than that of WCV. However, the immunogenicity of the two antigen preparations was comparable in terms of seroconversion for vibriocidal antibodies. These results demonstrate that VCG administered intraperitoneally evoke Vibrio-specific serum IgG responses as well as vibriocidal antibody activity in mice.
引用
收藏
页码:1330 / 1334
页数:5
相关论文
共 25 条
[1]  
BENENSON AS, 1968, B WORLD HEALTH ORGAN, V38, P277
[2]   PROTECTIVE EFFICACY IN HUMANS OF KILLED WHOLE-VIBRIO ORAL CHOLERA VACCINE WITH AND WITHOUT THE B-SUBUNIT OF CHOLERA-TOXIN [J].
BLACK, RE ;
LEVINE, MM ;
CLEMENTS, ML ;
YOUNG, CR ;
SVENNERHOLM, AM ;
HOLMGREN, J .
INFECTION AND IMMUNITY, 1987, 55 (05) :1116-1120
[3]  
CHONGSA-NGUAN M, 1987, Southeast Asian Journal of Tropical Medicine and Public Health, V18, P33
[4]   IMMUNOGENICITY OF 2 FORMULATIONS OF ORAL CHOLERA VACCINES IN THAI VOLUNTEERS [J].
CHONGSANGUAN, M ;
CHAICUMPA, W ;
RUANGKUNAPORN, Y ;
LOOAREESUWAN, S .
VACCINE, 1991, 9 (01) :53-59
[5]  
CLEMENS JD, 1986, LANCET, V2, P124
[6]   FIELD TRIAL OF ORAL CHOLERA VACCINES IN BANGLADESH - SERUM VIBRIOCIDAL AND ANTITOXIC ANTIBODIES AS MARKERS OF THE RISK OF CHOLERA [J].
CLEMENS, JD ;
VANLOON, F ;
SACK, DA ;
CHAKRABORTY, J ;
RAO, MR ;
AHMED, F ;
HARRIS, JR ;
KHAN, MR ;
YUNUS, M ;
HUDA, S ;
KAY, BA ;
SVENNERHOLM, AM ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1991, 163 (06) :1235-1242
[7]  
CLEMENTS ML, 1982, J INFECT DIS, V145, P468
[8]  
FORCARETA T, 1991, MOL MICROBIOL, V5, P2547
[9]   SEROEPIDEMIOLOGICAL STUDIES OF EL-TOR CHOLERA IN BANGLADESH - ASSOCIATION OF SERUM ANTIBODY-LEVELS WITH PROTECTION [J].
GLASS, RI ;
SVENNERHOLM, AM ;
KHAN, MR ;
HUDA, S ;
HUQ, MI ;
HOLMGREN, J .
JOURNAL OF INFECTIOUS DISEASES, 1985, 151 (02) :236-242
[10]   IMMUNE-RESPONSE RELATED TO THE MOLECULAR-STRUCTURE OF A PEPTIDE FROM THE CHOLERA-TOXIN B-SUBUNIT [J].
HALIMI, H ;
RIVAILLE, P .
VACCINE, 1993, 11 (12) :1233-1239